BITMINE IMMERSION TECHNOLOGI (BMNR) Stock Fundamental Analysis

USA NYSE Arca NYSEARCA:BMNR • US09175A2069

21.45 USD
+0.98 (+4.79%)
At close: Feb 9, 2026
21.16 USD
-0.29 (-1.35%)
After Hours: 2/9/2026, 9:46:42 PM
Fundamental Rating

2

Taking everything into account, BMNR scores 2 out of 10 in our fundamental rating. BMNR was compared to 277 industry peers in the Software industry. BMNR may be in some trouble as it scores bad on both profitability and health. BMNR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • BMNR had negative earnings in the past year.
  • BMNR had a negative operating cash flow in the past year.
  • BMNR had negative earnings in each of the past 5 years.
  • In the past 5 years BMNR always reported negative operating cash flow.
BMNR Yearly Net Income VS EBIT VS OCF VS FCFBMNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • With a Return On Assets value of -87.46%, BMNR is not doing good in the industry: 91.70% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -229.93%, BMNR is doing worse than 84.48% of the companies in the same industry.
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROIC N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMNR Yearly ROA, ROE, ROICBMNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • BMNR's Gross Margin of 16.39% is on the low side compared to the rest of the industry. BMNR is outperformed by 84.84% of its industry peers.
  • The Profit Margin and Operating Margin are not available for BMNR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMNR Yearly Profit, Operating, Gross MarginsBMNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

2

2. Health

2.1 Basic Checks

  • BMNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BMNR has been increased compared to 1 year ago.
  • The debt/assets ratio for BMNR is higher compared to a year ago.
BMNR Yearly Shares OutstandingBMNR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BMNR Yearly Total Debt VS Total AssetsBMNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • BMNR has an Altman-Z score of 1059.87. This indicates that BMNR is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 1059.87, BMNR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.90 indicates that BMNR is somewhat dependend on debt financing.
  • BMNR's Debt to Equity ratio of 0.90 is on the low side compared to the rest of the industry. BMNR is outperformed by 74.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 1059.87
ROIC/WACCN/A
WACC11.18%
BMNR Yearly LT Debt VS Equity VS FCFBMNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 0.25 indicates that BMNR may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.25, BMNR is doing worse than 96.03% of the companies in the same industry.
  • BMNR has a Quick Ratio of 0.25. This is a bad value and indicates that BMNR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BMNR has a worse Quick ratio (0.25) than 95.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
BMNR Yearly Current Assets VS Current LiabilitesBMNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

4

3. Growth

3.1 Past

  • The earnings per share for BMNR have decreased strongly by -100.71% in the last year.
  • Looking at the last year, BMNR shows a very strong growth in Revenue. The Revenue has grown by 158.36%.
EPS 1Y (TTM)-100.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%

3.2 Future

  • Based on estimates for the next years, BMNR will show a very strong growth in Earnings Per Share. The EPS will grow by 39.70% on average per year.
  • The Revenue is expected to grow by 58.95% on average over the next years. This is a very strong growth
EPS Next Y61.36%
EPS Next 2Y50.55%
EPS Next 3Y39.7%
EPS Next 5YN/A
Revenue Next Year109.52%
Revenue Next 2Y58.95%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BMNR Yearly Revenue VS EstimatesBMNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2M 4M 6M 8M
BMNR Yearly EPS VS EstimatesBMNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.5 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

  • BMNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 60.95, BMNR can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BMNR.
  • The average S&P500 Price/Forward Earnings ratio is at 27.86. BMNR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 60.95
BMNR Price Earnings VS Forward Price EarningsBMNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMNR Per share dataBMNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BMNR's earnings are expected to grow with 39.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.55%
EPS Next 3Y39.7%

2

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.06%, BMNR is not a good candidate for dividend investing.
  • The stock price of BMNR dropped by -37.65% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • BMNR's Dividend Yield is rather good when compared to the industry average which is at 0.61. BMNR pays more dividend than 88.81% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, BMNR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.06%

5.2 History

  • BMNR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
BMNR Yearly Dividends per shareBMNR Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.01 0.02

5.3 Sustainability

DPN/A
EPS Next 2Y50.55%
EPS Next 3Y39.7%
BMNR Yearly Income VS Free CF VS DividendBMNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 -2M -4M -6M

BITMINE IMMERSION TECHNOLOGI

NYSEARCA:BMNR (2/9/2026, 9:46:42 PM)

After market: 21.16 -0.29 (-1.35%)

21.45

+0.98 (+4.79%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-13
Earnings (Next)N/A
Inst Owners21.08%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change-48.51%
Market Cap8.24B
Revenue(TTM)4.63M
Net Income(TTM)-6.56M
Analysts82.5
Price Target49.64 (131.42%)
Short Float %7.42%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield 0.06%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.03%
PT rev (3m)-18.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 60.95
P/S 1781.02
P/FCF N/A
P/OCF N/A
P/B 2887.39
P/tB 2887.39
EV/EBITDA N/A
EPS(TTM)-2.81
EYN/A
EPS(NY)0.35
Fwd EY1.64%
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.39%
FCFM N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.43%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 1059.87
F-Score3
WACC11.18%
ROIC/WACCN/A
Cap/Depr(3y)65716%
Cap/Depr(5y)N/A
Cap/Sales(3y)508.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
EPS Next Y61.36%
EPS Next 2Y50.55%
EPS Next 3Y39.7%
EPS Next 5YN/A
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%
Revenue Next Year109.52%
Revenue Next 2Y58.95%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y95.32%
OCF growth 3YN/A
OCF growth 5YN/A

BITMINE IMMERSION TECHNOLOGI / BMNR FAQ

What is the ChartMill fundamental rating of BITMINE IMMERSION TECHNOLOGI (BMNR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BMNR.


Can you provide the valuation status for BITMINE IMMERSION TECHNOLOGI?

ChartMill assigns a valuation rating of 2 / 10 to BITMINE IMMERSION TECHNOLOGI (BMNR). This can be considered as Overvalued.


What is the profitability of BMNR stock?

BITMINE IMMERSION TECHNOLOGI (BMNR) has a profitability rating of 0 / 10.


Can you provide the financial health for BMNR stock?

The financial health rating of BITMINE IMMERSION TECHNOLOGI (BMNR) is 2 / 10.